Ramesh Panchagnula
Department of Pharmaceutics
National Institute of Pharmaceutical Education and Research
SAS Nagar
Punjab
India
Name/email consistency: high
- Effect of amorphous content on dissolution characteristics of rifampicin. Panchagnula, R., Bhardwaj, V. Drug. Dev. Ind. Pharm (2008)
- Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study. Panchagnula, R., Kumar Bajpai, A., Agrawal, S., Ashokraj, Y. Pharmazie (2006)
- Stability of insulin under iontophoretic conditions. Panchagnula, R., Bindra, P., Kumar, N., Dey, C.S., Pillai, O. Pharmazie (2006)
- Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinations. Panchagnula, R., Parmar, J., Kaur, J.K., Singh, I., Bhade, S.R. Methods. Find. Exp. Clin. Pharmacol (2006)
- Statistical evaluation of physiological variability of rifampicin in fixed dose combinations. Panchagnula, R., Parmar, J., Kaur, K., Singh, I., Bade, S.R., Ashokraj, Y. Int. J. Pharm (2006)
- An ex vivo characterization of Paclitaxel loaded chitosan films after implantation in mice. Panchagnula, R., Dhanikula, R.S., Dhanikula, A.B. Current. Drug. Delivery (2006)
- Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Panchagnula, R., Bokalial, R., Sharma, P., Khandavilli, S. Int. J. Pharm (2005)
- Single and multiple dose pharmacokinetic evaluation of a transdermal delivery system of imipramine hydrochloride. Panchagnula, R., Dravid, P., Jain, A., Khandavilli, S. Arzneimittelforschung (2005)
- Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation. Panchagnula, R., Desu, H., Jain, A., Khandavilli, S. Farmaco (2005)
- Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. Panchagnula, R., Bansal, T., Varma, M.V., Kaul, C.L. Pharmazie (2005)
- Solid-state characterization of mefenamic acid. Panchagnula, R., Sundaramurthy, P., Pillai, O., Agrawal, S., Raj, Y.A. J. Pharm. Sci (2004)
- Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicin. Panchagnula, R., Agrawal, S. Int. J. Pharm (2004)
- Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies. Panchagnula, R., Bansal, T., Varma, M.V., Kaul, C.L. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2004)
- Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. Panchagnula, R., Desu, H., Jain, A., Khandavilli, S. J. Pharm. Sci (2004)
- RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation. Panchagnula, R., Sharma, P., Khandavilli, S., Varma, M.V. Farmaco (2004)
- Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Panchagnula, R., Agrawal, S., Ashokraj, Y., Varma, M., Sateesh, K., Bhardwaj, V., Bedi, S., Gulati, I., Parmar, J., Kaul, C.L., Blomberg, B., Fourie, B., Roscigno, G., Wire, R., Laing, R., Evans, P., Moore, T. Methods. Find. Exp. Clin. Pharmacol (2004)
- Poloxamer gel as vehicle for transdermal iontophoretic delivery of arginine vasopressin: evaluation of in vivo performance in rats. Nair, V., Panchagnula, R. Pharmacol. Res. (2003)
- Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol. Panchagnula, R., Sancheti, P., Rungta, S., Agrawal, S., Kaul, C.L. Pharmacol. Res. (2003)
- Plasma pooling methodology as a faster and cheaper tool to evaluate bioequivalence of rifampicin component of FDCs of antitubercular drugs. Panchagnula, R., Sharma, A., Agrawal, S. Pharmacol. Res. (2003)
- Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Panchagnula, R., Salve, P.S., Thomas, N.S., Jain, A.K., Ramarao, P. Int. J. Pharm (2001)
- Transdermal iontophoresis revisited. Panchagnula, R., Pillai, O., Nair, V.B., Ramarao, P. Curr. Opin. Chem. Biol (2000)
- Nicotine transdermal systems: pharmaceutical and clinical aspects. Panchagnula, R., Jain, A.K., Pillai, O., Jaiswal, J. Methods. Find. Exp. Clin. Pharmacol (2000)
- Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol. Panchagnula, R., Agrawal, S., Kaur, K.J., Singh, I., Kaul, C.L. Int. J. Tuberc. Lung Dis. (2000)
- Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations. Panchagnula, R., Kaur, K.J., Singh, I., Kaul, C.L. Methods. Find. Exp. Clin. Pharmacol (2000)
- The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO. Panchagnula, R., Kaur, K.J., Singh, I., Kaul, C.L. Int. J. Tuberc. Lung Dis. (1999)
